Pfizer Inc (PFE) - Biopharma Revenue (I:PIPFEBR)
57.19B USD for 2023
Level Chart
Basic Info
Pfizer Inc (PFE) - Biopharma Revenue is at a current level of 57.19B, down from 98.99B one year ago. This is a change of -42.23% from one year ago. |
Biopharma Revenue refers to the sales of these products to various markets and customers, including healthcare providers, governments, and patients. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 57.19B |
Latest Period | 2023 |
Last Updated | Jan 31 2024, 08:41 EST |
Next Release | Jan 31 2025, 08:30 EST (E) |
Average Growth Rate | 21.17% |
Value from 1 Year Ago | 98.99B |
Change from 1 Year Ago | -42.23% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |
Historical Data
Date | Value |
---|---|
December 31, 2023 | 57.19B |
December 31, 2022 | 98.99B |
December 31, 2021 | 79.56B |
December 31, 2020 | 40.72B |
December 31, 2019 | 38.01B |
December 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
News
Headline
Wire
Time (ET)
Accesswire
11/15 12:05
PR Newswire
11/12 08:00
PR Newswire
11/05 05:00
PR Newswire
10/31 07:30
PR Newswire
10/30 06:30
PR Newswire
10/30 06:11
Basic Info
Pfizer Inc (PFE) - Biopharma Revenue is at a current level of 57.19B, down from 98.99B one year ago. This is a change of -42.23% from one year ago. |
Biopharma Revenue refers to the sales of these products to various markets and customers, including healthcare providers, governments, and patients. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 57.19B |
Latest Period | 2023 |
Last Updated | Jan 31 2024, 08:41 EST |
Next Release | Jan 31 2025, 08:30 EST (E) |
Average Growth Rate | 21.17% |
Value from 1 Year Ago | 98.99B |
Change from 1 Year Ago | -42.23% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |